Today

Agents

Chat

Arena

Discover

More

App

Theriva Biologics Q2 Net Income USD -3.217 Million - TOVX News | Rallies

Theriva Biologics Q2 Net Income USD -3.217 Million

TOVX•2026-08-11

Q2 results

Aug. 11 (Reuters) - Theriva Biologics Q2 income from operations was USD -3.295 million.

Q2 pretax profit: USD -3.217 million.

Related News

French press body asks competition watchdog to take action over Google AI

GOOGL•2026-08-11

Tripadvisor partners with Airbnb to offer select tours and activities for booking on platform

TRIP•2026-08-11

Cognyte showcases financial crimes investigation technology at IAFCI International Conference

CGNT•2026-08-11

CPP Investments, ReNew founder Sumant Sinha lift buyout offer for ReNew to USD 7.02 per share

RNW•2026-08-11

Electrovaya cuts FY2026 normalized revenue outlook to US$70 million-US$73 million

ELVA•2026-08-11